Study Stopped
resident left and no one to take over
Safety Study of Inhaling Carbon Monoxide in Healthy Volunteers
Safety and Tolerability of Inhaled Carbon Monoxide in Healthy Volunteers
1 other identifier
interventional
10
1 country
1
Brief Summary
Post operative ileus (POI), a temporary paralysis of the intestines, is a serious health care problem. It normally occurs in all patients after surgery to the abdomen but in some cases can result in serious complications. The objective of this study is to determine if inhaling very low doses of carbon monoxide (CO) before and after colon surgery will shorten the duration of normal POI and/or prevent the development of POI complications in patients undergoing colon surgery. This preliminary study will be conducted in ten healthy volunteers to monitor for blood levels and adverse effects that occur at different durations of exposure of inhaled CO to establish a safe dose for patients in the main trial. For the main trial, patients requiring surgery to their colon will be assigned randomly to receive one hour treatments of either CO or oxygen by face mask before and after their operation. We hypothesize that healthy volunteers will be able to tolerate 1 hour doses of 250 ppm of CO with minimal side effects. It is also anticipated that for each dose of CO administered, the blood levels of CO will remain well under poisonous levels. Finally, we anticipate blood levels of CO will return to baseline level within 24 hours following the last dose of CO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 healthy
Started Sep 2010
Longer than P75 for phase_1 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2010
CompletedFirst Posted
Study publicly available on registry
January 18, 2010
CompletedStudy Start
First participant enrolled
September 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedNovember 17, 2015
November 1, 2015
9 months
January 13, 2010
November 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adverse Event Rate
Before and after carbon monoxide exposure
Study Arms (1)
Carbon Monoxide
EXPERIMENTALHealthy volunteers will receive 250 ppm of carbon monoxide by face mask. This dose will be administered for 1 hour with continuous COHb monitoring. At baseline and at each half hour time point, a blood sample will be drawn to be analyzed by the gas chromatograph. After 1 hour, the volunteer will be excused and asked to return in 4 hours and this procedure repeated. At any point, if the COHb level reaches 10%, administration of CO will be terminated.
Interventions
Eligibility Criteria
You may qualify if:
- Men and women, age \> 18 years.
- Women must be using acceptable contraceptives, post-menopausal or surgically sterile.
- No prior smoking history.
- BMI between 16 and 30 inclusive.
- In good health as per medical history, physical exam, vital signs \& ECG.
You may not qualify if:
- Exposure to carbon monoxide during the 48 hours prior to the study day.
- Occupational exposure to CO.
- Significant disease that may put the volunteer at risk because of participation in the study or may influence the results of the study or the volunteer's ability to participate in the study.
- Baseline blood level of COHb \>2%.
- Patients with underlying lung disease such as asthma or COPD.
- Baseline oxygen saturation \<92% on room air.
- Planned pregnancy, already pregnant or breastfeeding.
- Participation in another clinical trial within 2 months prior to study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kingston General Hospital
Kingston, Ontario, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Belliveau, MD
Queen's University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 13, 2010
First Posted
January 18, 2010
Study Start
September 1, 2010
Primary Completion
June 1, 2011
Study Completion
October 1, 2011
Last Updated
November 17, 2015
Record last verified: 2015-11